BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$89.13
+1.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.13x
- Price / sales
- 7.59x
- Price / cash flow
- 27.24x
Enterprise value
- Enterprise value
- $11.9B
- EV / sales
- 4.03x
- EV / EBITDA
- -11.32x
- EV / EBIT
- -5.61x
- Market cap
- $22.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026